Broenstrup; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Broenstrup; Mark.The latest application filed is for "targeted cytotoxic ratjadone derivatives and conjugates thereof".

Company Profile

3.16.17

Broenstrup; Mark - Braunschweig DE
BROENSTRUP; Mark - Frankfurt am Main DE
Broenstrup; Mark - Frankfurt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeted cytotoxic ratjadone derivatives and conjugates thereof Grant 11,236,059 - Klahn , et al. February 1, 2	2022-02-01
1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use Grant 11,072,590 - Broenstrup , et al. July 27, 2	2021-07-27
Targeted Cytotoxic Ratjadone Derivatives And Conjugates Thereof App 20200239426 - KLAHN; Philipp ; et al.	2020-07-30
Method for Producing Recombinant 11-De-O-Methyltomaymycin App 20200216852 - LATTEMANN; Claus ; et al.	2020-07-09
Method for producing recombinant 11-de-O-methyltomaymycin Grant 10,550,397 - Lattemann , et al. Fe	2020-02-04
Method and measuring device for determination of the growth rate of biofilm Grant 10,520,488 - Van Duuren , et al. Dec	2019-12-31
Method and Measuring Device for Determination of the Growth Rate of Biofilm App 20170350875 - VAN DUUREN; Jost ; et al.	2017-12-07
1,4,7,10-tetrazacyclododecane Based Agents To Target Bacteria And Its Use App 20170240582 - BROENSTRUP; Mark ; et al.	2017-08-24
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,688,645 - Kallus , et al. June 27, 2	2017-06-27
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160251324 - KALLUS; Christopher ; et al.	2016-09-01
Gene cluster for biosynthesis of griselimycin and methylgriselimycin Grant 9,422,566 - Broenstrup , et al. August 23, 2	2016-08-23
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,309,207 - Kallus , et al. April 12, 2	2016-04-12
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20160024033 - KALLUS; Christopher ; et al.	2016-01-28
Method For Recombinant Production Of Labyrinthopeptins And Functional Derivatives Thereof App 20150274787 - Wink; Joachim ; et al.	2015-10-01
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 9,126,955 - Kallus , et al. September 8, 2	2015-09-08
Method for Producing Recombinant 11-De-O-Methyltomaymycin App 20150111298 - Lattemann; Claus ; et al.	2015-04-23
Gene Cluster For Biosynthesis Of Griselimycin And Methylgriselimycin App 20140295457 - Broenstrup; Mark ; et al.	2014-10-02
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140206760 - Kallus; Christopher ; et al.	2014-07-24
Macrocyclic urea and sulfamide derivatives as inhibitors of tafia Grant 8,722,655 - Kallus , et al. May 13, 2	2014-05-13
Macrocyclic Urea And Sulfamide Derivatives As Inhibitors Of Tafia App 20140039011 - Kallus; Christopher ; et al.	2014-02-06
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,580,777 - Kallus , et al. November 12, 2	2013-11-12
Isolated peptides from Actinomadura namibiensis Grant 8,476,222 - Seibert , et al. July 2, 2	2013-07-02
Urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,389,764 - Kallus , et al. March 5, 2	2013-03-05
MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20110178130 - Kallus; Christopher ; et al.	2011-07-21
Highly Bridged Peptides From Actinomadura Namibiensis App 20110144001 - BROENSTRUP; Mark ; et al.	2011-06-16
UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20100035930 - KALLUS; Christopher ; et al.	2010-02-11
Novel Peptides From Actinomadura Namibiensis App 20090298904 - Seibert; Gerhard ; et al.	2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.